These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 3525866

  • 1. A comparison of the effect of diethylstilbestrol with low dose estramustine phosphate in the treatment of advanced prostatic cancer: final analysis of a phase III trial of the European Organization for Research on Treatment of Cancer.
    Smith PH, Suciu S, Robinson MR, Richards B, Bastable JR, Glashan RW, Bouffioux C, Lardennois B, Williams RE, de Pauw M.
    J Urol; 1986 Sep; 136(3):619-23. PubMed ID: 3525866
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Estramustine phosphate as primary therapy for metastatic prostate cancer. Preliminary results of the University of Wisconsin trial.
    Benson RC.
    Urology; 1984 Jun; 23(6 Suppl):69-72. PubMed ID: 6375084
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of diethylstilbestrol, cyproterone acetate and medroxyprogesterone acetate in the treatment of advanced prostatic cancer: final analysis of a randomized phase III trial of the European Organization for Research on Treatment of Cancer Urological Group.
    Pavone-Macaluso M, de Voogt HJ, Viggiano G, Barasolo E, Lardennois B, de Pauw M, Sylvester R.
    J Urol; 1986 Sep; 136(3):624-31. PubMed ID: 2942707
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. French multicenter study on the use of estramustine phosphate versus diethylstilbestrol.
    Hauchecorne J.
    Prog Clin Biol Res; 1987 Sep; 243B():229-34. PubMed ID: 3309983
    [No Abstract] [Full Text] [Related]

  • 7. A randomized double blind crossover trial of diethylstilbestrol (DES) and estramustine phosphate (Emcyt) for stage D prostatic carcinoma.
    Benson RC, Gill GM, Cummings KB.
    Semin Oncol; 1983 Sep; 10(3 Suppl 3):43-5. PubMed ID: 6364366
    [No Abstract] [Full Text] [Related]

  • 8. Estramustine phosphate versus stilbestrol as primary treatment for metastatic cancer of the prostate.
    Nickel CJ, Morales A.
    Can J Surg; 1983 Sep; 26(5):434-8. PubMed ID: 6351988
    [Abstract] [Full Text] [Related]

  • 9. Estramustine phosphate in prostate cancer. EORTC experience: preliminary results of Protocol 30762.
    Smith PH, Robinson M, Richards B, Suciu S, De Pauw M, Sylvester R, Denis L.
    Urology; 1984 Jun; 23(6 Suppl):64-8. PubMed ID: 6375083
    [No Abstract] [Full Text] [Related]

  • 10. The EORTC Phase III trials in prostatic cancer.
    Robinson MR, Smith PH, Macaluso MP, Sylvester R, de Voogt H.
    Prog Clin Biol Res; 1985 Jun; 185A():243-9. PubMed ID: 3898132
    [No Abstract] [Full Text] [Related]

  • 11. Estramustine phosphate compared with diethylstilbestrol. A randomized, double-blind, crossover trial for stage D prostate cancer.
    Benson RC, Gill GM.
    Am J Clin Oncol; 1986 Aug; 9(4):341-51. PubMed ID: 3529921
    [Abstract] [Full Text] [Related]

  • 12. Results of another trial of chemotherapy with and without hormones in patients with newly diagnosed metastatic prostate cancer.
    Murphy GP, Huben RP, Priore R.
    Urology; 1986 Jul; 28(1):36-40. PubMed ID: 3523938
    [Abstract] [Full Text] [Related]

  • 13. Clinical relevance of plasma testosterone and prolactin changes in advanced cancer of prostate treated with diethylstilbestrol or estramustine phosphate.
    Morales A, Nickel JC.
    Urology; 1985 Nov; 26(5):477-81. PubMed ID: 3904134
    [Abstract] [Full Text] [Related]

  • 14. Change in white cell count during treatment of advanced cancer of the prostate with estramustine phosphate and with stilboestrol.
    Daponte D, Sylvester R, De Pauw M, Fryszman A, Smith RM, Smith PH.
    Br J Urol; 1983 Aug; 55(4):408-12. PubMed ID: 6349745
    [Abstract] [Full Text] [Related]

  • 15. Experiences with estramustine phosphate (Estracyt, Emcyt) in prostate cancer.
    Murphy GP, Slack NH, Mittelman A.
    Semin Oncol; 1983 Sep; 10(3 Suppl 3):34-42. PubMed ID: 6364365
    [No Abstract] [Full Text] [Related]

  • 16. Effect of treatment with diethylstilbestrol-polyestradiol phosphate or estramustine phosphate (estracyt) on natural killer cell activity in patients with prostatic cancer.
    Kalland T, Haukaas S.
    Invest Urol; 1981 May; 18(8):437-9. PubMed ID: 7228576
    [Abstract] [Full Text] [Related]

  • 17. Prostatic cancer. Transcortin levels during treatment with estramustine phosphate.
    Sandberg AA, Rosenthal H, Mittelman A, Murphy GP.
    Urology; 1975 Jul; 6(1):17-21. PubMed ID: 1145919
    [Abstract] [Full Text] [Related]

  • 18. Effects of diethylstilbestrol and estramustine phosphate on serum sex hormone binding globulin and testosterone levels in prostate cancer patients.
    Karr JP, Wajsman Z, Kirdani RY, Murphy GP, Sandberg AA.
    J Urol; 1980 Aug; 124(2):232-6. PubMed ID: 7190620
    [Abstract] [Full Text] [Related]

  • 19. Estramustine phosphate therapy in carcinoma of the prostate.
    Andersson L, Edsmyr F, Jönsson G, Könyves I.
    Recent Results Cancer Res; 1977 Aug; (60):73-7. PubMed ID: 866798
    [Abstract] [Full Text] [Related]

  • 20. Multivariate analysis of prognostic factors in patients with advanced prostatic cancer: results from 2 European Organization for Research on Treatment of Cancer trials.
    de Voogt HJ, Suciu S, Sylvester R, Pavone-Macaluso M, Smith PH, de Pauw M.
    J Urol; 1989 Apr; 141(4):883-8. PubMed ID: 2522561
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.